TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CAPR

Capricor Therapeutics Inc

Healthcare · Biotechnology

8.40$ -2.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Capricor Therapeutics Inc (CAPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -70 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CAPR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1.0 -11 -16 -14 -14 -6.8 -10 -17 4.9 -26 -40 -70
0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.5 1.1 1.4 1.9
0.5 1.6 2.0 1.7 1.7 0.7 2.0 3.0 4.5 7.4 9.8 17
0.5 1.6 3.5 1.7 1.7 0.7 2.0 2.8 4.5 – – –
6.6 0.4 -0.6 -2.9 -0.6 -0.1 1.5 0.2 29 -12 -11 12
0.2 0.2 0.2 0.0 0.3 0.5 0.5 1.2 3.4 2.0 1.5 2.9
0.1 -8.1 -5.2 5.0 4.7 -3.0 5.4 -1.2 -35 5.1 -116 97
0.0 0.0 0.0 0.0 – – – – – – – –
0.0 16 14 11 6.9 0.0 33 20 4.9 – – –
5.2 4.8 4.8 0.5 0.3 0.3 0.3 0.0 – – – –
5.2 16 19 12 6.9 9.2 33 20 4.9 26 153 249
6.3 -2.5 -2.4 2.3 -2.3 -0.6 29 2.2 -25 5.1 -3.4 277
0.8 -11 -16 -14 -14 -6.8 -11 -18 1.6 -28 -42 -73

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?